首页> 美国卫生研究院文献>AAPS PharmSci >Evaluation of the Microcentrifuge Dissolution Method as a Tool for Spray-Dried Dispersion
【2h】

Evaluation of the Microcentrifuge Dissolution Method as a Tool for Spray-Dried Dispersion

机译:微量离心机溶解方法作为喷雾干燥分散剂的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although using spray-dried dispersions (SDDs) to improve the bioavailability of poorly water-soluble compounds has become a common practice in supporting the early phases of clinical studies, their performance evaluation, whether in solid dosage forms or alone, still presents significant challenges. A microcentrifuge dissolution method has been reported to quickly assess the dissolution performance of SDDs. While the microcentrifuge dissolution method has been used in the SDD community, there is still a need to understand the mechanisms about the molecular species present in supernatant after centrifugation, the molecular nature of active pharmaceutical ingredients (APIs), as well as the impact of experimental conditions. In this paper, we aim to assess the effect of API and polymer properties on the dissolution behavior of SDDs along with centrifuging parameters, and for this, two poorly water-soluble compounds (indomethacin and ketoconazole) and two commonly used polymers in the pharmaceutical industry (PVP and HPMC-AS) were chosen to prepare SDDs. A typical microcentrifuge dissolution procedure as reported in the publication (Curatolo et al., Pharm Res 26:1419–1431, ) was followed. In addition, after separation of the supernatant from precipitation, some of the samples were filtered through filters of various sizes to investigate the particulate nature (particle size) of the supernatant. Furthermore, the centrifuge speed was varied to study sedimentation of API, SDD, or polymer particles. The results indicated that for the SDDs of four drug-polymer pairs, microcentrifuge dissolution exhibited varied behaviors, depending on the polymer and the drug used. The SDDs of indomethacin with either PVP or HPMC-AS showed a reproducible dissolution with minimum variability even after filtration and subjecting to varied centrifugation speed, suggesting that the supernatant behaved solution-like. However, ketoconazole-PVP and ketoconazole-HPMC-AS SDDs displayed a significant variation in concentration as the speed of centrifugation and the pore sizes of filters were altered, indicating that their supernatant was heterogeneous with the presence of particulates. In conclusion, microcentrifuge dissolution method was more suitable for indomethacin-PVP and indomethacin-HPMC-AS systems compared with ketoconazole-PVP and ketoconazole-HPMC-AS. Therefore, the use of microcentrifuge dissolution method depends on both compounds and polymers selected, which should be examined case by case.
机译:尽管使用喷雾干燥的分散液(SDD)改善水溶性差的化合物的生物利用度已成为支持临床研究早期阶段的一种常见做法,但无论是固体剂型还是单独使用,其性能评估仍面临重大挑战。已经报道了微量离心溶解方法来快速评估SDD的溶解性能。尽管SDD社区已使用微量离心机溶解方法,但仍需要了解离心后上清液中存在的分子种类的机制,活性药物成分(API)的分子性质以及实验的影响条件。在本文中,我们旨在评估API和聚合物性质对SDDs溶解行为以及离心参数的影响,为此,将两种水溶性差的化合物(吲哚美辛和酮康唑)和两种在制药行业中常用的聚合物(PVP和HPMC-AS)被选择来准备SDD。遵循出版物(Curatolo等,Pharm Res 26:1419–1431,)中报道的典型的微量离心机溶解程序。另外,从沉淀物中分离出上清液后,将一些样品通过各种尺寸的过滤器过滤以研究上清液的颗粒性质(粒度)。此外,改变离心速度以研究API,SDD或聚合物颗粒的沉降。结果表明,对于四种药物-聚合物对的SDD,微量离心溶解表现出不同的行为,具体取决于聚合物和所用药物。吲哚美辛与PVP或HPMC-AS的SDD均显示出可重现的溶出度,即使经过过滤并具有不同的离心速度,其变化也很小,表明上清液呈溶液状。然而,随着离心速度和过滤器孔径的改变,酮康唑-PVP和酮康唑-HPMC-AS SDDs的浓度显示出显着变化,表明它们的上清液由于存在颗粒而异质。总之,与酮康唑-PVP和酮康唑-HPMC-AS相比,微量离心溶解方法更适合于吲哚美辛-PVP和吲哚美辛-HPMC-AS系统。因此,微量离心机溶解方法的使用取决于所选择的化合物和聚合物,应逐案检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号